ProBio, the CDMO division of GenScript Biotech, is a global biologics and cell and gene therapy CDMO headquartered in New Jersey, with additional offices in China, Hong Kong, the Netherlands, Japan, and South Korea. The company provides end-to-end services from discovery through commercialization, including therapeutic antibody discovery, engineering, and characterization, as well as large-scale mRNA and oligonucleotide production. ProBio supports vaccines, biologics, and advanced therapies with integrated, efficient, and cGMP-compliant development and manufacturing solutions.